Hepatobiliary Cancer Risk in Patients with Inflammatory Bowel Disease: A Scandinavian Population-Based Cohort Study-Reference-Cited by-同舟云学术

Hepatobiliary Cancer Risk in Patients with Inflammatory Bowel Disease: A Scandinavian Population-Based Cohort Study

Published:2021-02-24 Issue:5 Volume:30 Page:886-894
ISSN:1055-9965
Container-title:Cancer Epidemiology Biomarkers & Prevention
language:en
Short-container-title:Cancer Epidemiol Biomarkers Prev

Author:

Erichsen Rune,Olén Ola,Sachs Michael C.^ORCID,Pedersen Lars,Halfvarson Jonas,Askling Johan,Ekbom Anders,Ludvigsson Jonas F.,Sørensen Henrik Toft^ORCID

Funder

Independent Research Fund Denmark

Novo Nordisk Foundation

Swedish Societyof Medicine

Clinical Research between Stockholm County Council and Karolinska Institutet

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology,Epidemiology

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Causal association between inflammatory bowel disease and 32 site-specific extracolonic cancers: a Mendelian randomization study;BMC Medicine;2023-10-10

2. Prevalence of Hepatobiliary Manifestations in Inflammatory Bowel Disease: A GRADE Assessed Systematic Review and Meta-Analysis of more than 1.7 Million Patients;Journal of Crohn's and Colitis;2023-09-11

3. Incidence of cancer in patients with ulcerative colitis 30 years after diagnosis (the IBSEN study);Scandinavian Journal of Gastroenterology;2023-06-20

4. Risk Factors of Cancer in Pediatric-Onset Inflammatory Bowel Disease in Denmark and Finland;Journal of Pediatric Gastroenterology & Nutrition;2023-03-24

5. Increased Risk of Cancer and Mortality in a Large French Population-Based Paediatric-Onset Inflammatory Bowel Disease Retrospective Cohort;Journal of Crohn's and Colitis;2022-11-01